Personal information

Activities

Employment (3)

University of California San Francisco: San Francisco, CA, US

Employment
Source: Self-asserted source
Andrew Wolfe

Mount Sinai School of Medicine: New York, NY, US

Employment
Source: Self-asserted source
Andrew Wolfe

Memorial Sloan Kettering Cancer Center: New York, NY, US

Employment
Source: Self-asserted source
Andrew Wolfe

Education and qualifications (2)

Weill Cornell Graduate School of Medical Sciences: New York, NY, US

Education
Source: Self-asserted source
Andrew Wolfe

University of California Los Angeles: Los Angeles, CA, US

Education
Source: Self-asserted source
Andrew Wolfe

Funding (4)

RaMP: Diversifying the National Biology Workforce through New York Transdisciplinary BioSciences (NY-RaMP)

2023-08-01 to 2027-07-31 | Grant
Directorate for Biological Sciences (Alexandria, US)
GRANT_NUMBER: 2318923
Source: Self-asserted source
Andrew Wolfe via DimensionsWizard

Cellular mechanisms and therapeutic possibilities of inhibiting oncogenic KRAS

2018-09-01 to 2025-08-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: R00CA226363
Source: Self-asserted source
Andrew Wolfe via DimensionsWizard

Cellular mechanisms and therapeutic possibilities of inhibiting oncogenic KRAS

2018-09-01 to 2021-08-31 | Grant
National Cancer Institute (Bethesda, US)
GRANT_NUMBER: K99CA226363
Source: Self-asserted source
Andrew Wolfe via DimensionsWizard

PTEN-L: Physiological function, regulation, and therapeutic possibilities

2015-01-01 to 2018-12-31 | Grant
Damon Runyon Cancer Research Foundation (New York, US)
GRANT_NUMBER:

DRG-2214-15

Source: Self-asserted source
Andrew Wolfe via DimensionsWizard

Works (16)

IMPlications of IMP2 in RNA Biology and Disease

International Journal of Molecular Sciences
2025-03-07 | Journal article
Contributors: Jessica Das; Ottavia Busia-Bourdain; Khizr M. Khan; Andrew L. Wolfe
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Cadherin-17 as a target for the immunoPET of adenocarcinoma

European Journal of Nuclear Medicine and Molecular Imaging
2024-07 | Journal article
Part of ISSN: 1619-7070
Part of ISSN: 1619-7089
Contributors: Samantha Delaney; Outi Keinänen; Dennis Lam; Andrew L. Wolfe; Takao Hamakubo; Brian Zeglis
Source: Self-asserted source
Andrew Wolfe

Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function

2024-07-16 | Preprint
Contributors: Dennis Lam; Brandon Arroyo; Ariel N. Liberchuk; Andrew L. Wolfe
Source: check_circle
Crossref

KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance

Current Oncology
2024-04-03 | Journal article
Part of ISSN: 1718-7729
Contributors: Leonard J. Ash; Ottavia Busia-Bourdain; Daniel Okpattah; Avrosina Kamel; Ariel Liberchuk; Andrew L. Wolfe
Source: Self-asserted source
Andrew Wolfe

Targeting cancer’s sweet spot: UGP2 as a therapeutic vulnerability

Molecular & Cellular Oncology
2021-11-02 | Journal article
Contributors: Sunghoon Kim; Andrew Wolfe; Sung Eun Kim
Source: check_circle
Crossref

UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth

Proceedings of the National Academy of Sciences
2021-08-03 | Journal article
Contributors: Andrew L. Wolfe; Qingwen Zhou; Eneda Toska; Jacqueline Galeas; Angel A. Ku; Richard P. Koche; Sourav Bandyopadhyay; Maurizio Scaltriti; Carlito B. Lebrilla; Frank McCormick et al.
Source: check_circle
Crossref

NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer

Communications Biology
2021-03-09 | Journal article
Part of ISSN: 2399-3642
Contributors: Kyrie Pappas; Tiphaine Martin; Andrew L. Wolfe; Christie B. Nguyen; Tao Su; Jian Jin; Hanina Hibshoosh; Ramon Parsons
Source: Self-asserted source
Andrew Wolfe

NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy.

Cancers
2021-02-05 | Journal article
Source: Self-asserted source
Andrew Wolfe

Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity.

Immunity
2017-12-12 | Journal article
Source: Self-asserted source
Andrew Wolfe

Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia.

Science signaling
2014-11-18 | Journal article
Source: Self-asserted source
Andrew Wolfe

RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer.

Nature
2014-07-27 | Journal article
Source: Self-asserted source
Andrew Wolfe

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.

Cell
2011-10-01 | Journal article
Source: Self-asserted source
Andrew Wolfe

Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma.

The Journal of experimental medicine
2011-08-22 | Journal article
Source: Self-asserted source
Andrew Wolfe

A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).

Nature genetics
2011-06-05 | Journal article
Source: Self-asserted source
Andrew Wolfe

Mouse models of cancer as biological filters for complex genomic data.

Disease models & mechanisms
2010-09-27 | Journal article
Source: Self-asserted source
Andrew Wolfe

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.

Nature cell biology
2010-02-28 | Journal article
Source: Self-asserted source
Andrew Wolfe